The global Crohn's disease market is expected to exhibit a strong 3.3% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The research report profiles the global Crohn's disease market in great detail and provides readers with a comprehensive overview of the market.
The market's historical growth trajectory, present conditions, and future growth prospects are studied in the report. The report provides a comprehensive overview of the market's historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report.
Crohn's disease is an inflammatory bowel disease and can affect any part of the digestive tract from the mouth to the anus. It is caused by a combination of immune, environmental, and bacterial factors in genetically predisposed individuals. It causes inflammation of the digestive tract and can result in abdominal pain, severe diarrhea, fatigue, and weight loss.
The global Crohn’s disease market is segmented on the basis of type, treatment, end-use, and region.
By type, the global Crohn’s disease market is segmented into ileocolitis, ileitis, granulomatous colitis, gastroduodenal Crohn's disease, jejunoileitis, and perianal Crohn's disease.
By treatment, the global Crohn’s disease market is segmented into non-surgical and surgical. The non-surgical segment is further sub-segmented into anti-inflammatory, immune system suppressors, antibiotics, and others. The anti-inflammatory segment is classified as corticosteroids and oral 5-aminosalicylates. The immune system suppressors segment is further sub-segmented into Azathioprine, Mercaptopurine, TNF inhibitors, Methotraxate, Natalizumab, Vedolizumab, and Ustekinumab.
The Americas dominate the global Crohn’s disease market, followed by Europe. The growing prevalence of Crohn’s disease in North America and the growing awareness about the disease in the region are the major drivers for the Crohn’s disease market in the Americas. North America is the leading regional segment within America, led by the U.S. Europe is also likely to hold an important share in the global Crohn’s disease market over the forecast period.